Loading InvisibleSignal...

Healthcare Cost Breakdown

Detailed analysis of medical costs for invisible illness patients by category

Total Annual Burden

~$39,180/yr

Largest Category

Lost Wages$12,000/yr

Highest Condition

Lymeup to $48K/yr

vs. Diabetes

2.3xhigher cost

Annual Cost by Category

Average annual healthcare spending for invisible illness patients across 9 cost categories

Lost Wages

$12,000

Specialist Visits

$6,800

Physician Visits

$4,200

Medications

$4,080

Alternative/Integrative

$3,600

Lab Tests

$3,400

Emergency Visits

$2,100

Travel for Care

$1,800

Medical Devices/Aids

$1,200

Total Annual Average~$39,180/yr

Condition-Specific Cost Comparison

Annual cost ranges by invisible illness condition (low to high)

Lyme Disease$28,000 – $48,000

Long COVID$9,000 – $35,000

POTS$15,000 – $30,000

ME/CFS$17,000 – $24,000

Fibromyalgia$12,000 – $22,000

Alpha-gal$5,000 – $15,000

Insurance Coverage Gap Analysis

What typical insurance plans cover vs. deny for invisible illness patients

Out-of-Pocket Burden by Condition

Lyme Disease48% OOP

ME/CFS55% OOP

Fibromyalgia42% OOP

POTS45% OOP

Long COVID38% OOP

Alpha-gal52% OOP

Comparison with Other Chronic Diseases

Average annual cost: invisible illness vs. commonly recognized chronic conditions

Invisible illness patients spend an average of 2.3x more than diabetes ($16,752/yr) and 2.1x more than heart disease ($18,953/yr) annually, yet receive significantly less research funding and insurance support.

Financial Toxicity Assessment

Estimate the financial impact of invisible illness costs relative to your household income

Annual Household Income: $65,000

$15K$130K$250K

Drag slider to adjust your estimated annual household income

Healthcare as % of Income

60.3%

~$39,180 of $65,000

Financial Toxicity Score

Severe

Monthly Burden

$3,265

per month in healthcare costs

Financial Toxicity Scale

0-20: Minimal

21-40: Low

41-60: Moderate

61-80: High

81-100: Severe

Scores above 60 indicate significant financial strain. The OECD defines healthcare spending above 10% of household income as “catastrophic health expenditure.”

Explore Related Modules

Cost Calculator

Per-patient cost estimates

National Dashboard

Aggregate economic burden

Insurance Navigator

Coverage & appeals guide

Funding Analysis

Research investment disparities

Data Sources (7)

AHRQ. Medical Expenditure Panel Survey (MEPS). 2023.
CMS. National Health Expenditure Data. 2024.
Johns Hopkins Bloomberg School of Public Health. Economic Burden of Lyme Disease. 2023.
Solve M.E.. The Cost of ME/CFS to Society. 2022.
Journal of General Internal Medicine. Financial Toxicity in Chronic Disease. 2023.
ADA. American Diabetes Association Cost of Diabetes. 2023.
American Heart Association. Heart Disease and Stroke Statistics. 2024.

Disclaimer

Cost estimates are based on published research, insurance claims data, and patient surveys. Individual costs vary significantly based on disease severity, geographic location, insurance coverage, and treatment protocols. Lost wages estimates use median U.S. wage data. This tool is for informational and advocacy purposes only and does not constitute financial or medical advice.